Literature DB >> 17377381

Angioedema in renal transplant recipients on sirolimus.

Emmanuel Mahé1, Emmanuel Morelon, Sophie Lechaton, Henri Kreis, Yves de Prost, Christine Bodemer.   

Abstract

BACKGROUND: Most drug-associated angioedemas are induced by angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, or nonsteroidal anti-inflammatory drugs. Recently, the responsibility of immunosuppressive agents given to transplant recipients in the development of angioedema has been discussed.
OBJECTIVE: To describe, in detail, angioedema episodes in renal transplant recipients (RTRs) on sirolimus.
METHODS: A cross-sectional study in a university hospital. Eighty consecutive RTRs on sirolimus were studied.
RESULTS: Angioedema without urticaria occurred a mean of 5 times in 12/80 (15%) RTRs taking sirolimus. It was predominantly located on the face (83%), with mucous membrane involvement in 7 (58%) patients, and was life threatening in 1. Another putative cofactor for angioedema without urticaria was identified in 9 (75%) patients: drugs (n=8), food allergy or physical activity (n=3). Tacrolimus intake was significantly associated with sirolimus-associated angioedema.
CONCLUSION: Our results suggested a causal relationship between sirolimus and angioedema in RTRs. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377381     DOI: 10.1159/000099584

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

1.  Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use.

Authors:  J B Byrd; A Woodard-Grice; E Stone; A Lucisano; H Schaefer; C Yu; A E Eyler; N E Salloum; N J Brown
Journal:  Allergy       Date:  2010-11       Impact factor: 13.146

Review 2.  [Drug-induced angioedema : Focus on bradykinin].

Authors:  B Sachs; T Meier; M M Nöthen; C Stieber; J Stingl
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

3.  Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients.

Authors:  Michael Duerr; Petra Glander; Fritz Diekmann; Duska Dragun; Hans-H Neumayer; Klemens Budde
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 8.237

4.  Palmoplantar peeling secondary to sirolimus therapy.

Authors:  L S Liu; J M McNiff; O R Colegio
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

Review 5.  Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs).

Authors:  Chems Gharbi; Victor Gueutin; Hassan Izzedine
Journal:  Clin Kidney J       Date:  2014-02-24

6.  ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation.

Authors:  Dushyanth Srinivasan; Garth W Strohbehn; Thomas Cascino
Journal:  ESC Heart Fail       Date:  2017-03-23

7.  Sirolimus-induced severe small bowel angioedema: A case report.

Authors:  Hui Yang; Wei Wang; Xiaopeng Hu; Xiaodong Zhang; Lihong Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.